Response to “Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real‐World Data”

per Müntze, Jonas, Nordbeck, Peter
Publicat a Clin Pharmacol Ther (2019)

Long‐term outcome after surgical repair of a rapid‐grown ischemic ventricular aneurysm causing ventricular tachycardia

per Gensler, Daniel, Müntze, Jonas, Nordbeck, Peter
Publicat a Clin Case Rep (2019)

Contemporary therapeutics and new drug developments for treatment of Fabry disease: a narrative review

per Oder, Daniel, Müntze, Jonas, Nordbeck, Peter
Publicat a Cardiovasc Diagn Ther (2021)

Treatment of hypertrophic cardiomyopathy caused by cardiospecific variants of Fabry disease with chaperone therapy

per Müntze, Jonas, Salinger, Tim, Gensler, Daniel, Wanner, Christoph, Nordbeck, Peter
Publicat a Eur Heart J (2018)

Hot topics in Fabry disease

per Cairns, Tereza, Müntze, Jonas, Gernert, Judith, Spingler, Lisa, Nordbeck, Peter, Wanner, Christoph
Publicat a Postgrad Med J (2018)

Impella CP use in patients with non‐ischaemic cardiogenic shock

per Maniuc, Octavian, Salinger, Tim, Anders, Fabian, Müntze, Jonas, Liu, Dan, Hu, Kai, Ertl, Georg, Frantz, Stefan, Nordbeck, Peter
Publicat a ESC Heart Fail (2019)

Cardiac and renal dysfunction is associated with progressive hearing loss in patients with Fabry disease

per Köping, Maria, Shehata-Dieler, Wafaa, Cebulla, Mario, Rak, Kristen, Oder, Daniel, Müntze, Jonas, Nordbeck, Peter, Wanner, Christoph, Hagen, Rudolf, Schraven, Sebastian
Publicat a PLoS One (2017)

Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year

per Müntze, Jonas, Gensler, Daniel, Maniuc, Octavian, Liu, Dan, Cairns, Tereza, Oder, Daniel, Hu, Kai, Lorenz, Kristina, Frantz, Stefan, Wanner, Christoph, Nordbeck, Peter
Publicat a Clin Pharmacol Ther (2019)

Association and diagnostic utility of diastolic dysfunction and myocardial fibrosis in patients with Fabry disease

per Liu, Dan, Oder, Daniel, Salinger, Tim, Hu, Kai, Müntze, Jonas, Weidemann, Frank, Herrmann, Sebastian, Ertl, Georg, Wanner, Christoph, Frantz, Stefan, Störk, Stefan, Nordbeck, Peter
Publicat a Open Heart (2018)

Clinical impact of the alpha-galactosidase A gene single nucleotide polymorphism -10C>T: A single-center observational study

per Oder, Daniel, Liu, Dan, Üçeyler, Nurcan, Sommer, Claudia, Hu, Kai, Salinger, Tim, Müntze, Jonas, Petritsch, Bernhard, Ertl, Georg, Wanner, Christoph, Nordbeck, Peter, Weidemann, Frank
Publicat a Medicine (Baltimore) (2018)

Value of the CHA(2)DS(2)-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillation

per Liu, Dan, Hu, Kai, Schmidt, Marie, Müntze, Jonas, Maniuc, Octavian, Gensler, Daniel, Oder, Daniel, Salinger, Tim, Weidemann, Frank, Ertl, Georg, Frantz, Stefan, Wanner, Christoph, Nordbeck, Peter
Publicat a Clin Res Cardiol (2018)

Association between Comorbidities and Progression of Transvalvular Pressure Gradients in Patients with Moderate and Severe Aortic Valve Stenosis

per Salinger, Tim, Hu, Kai, Liu, Dan, Taleh, Scharoch, Herrmann, Sebastian, Oder, Daniel, Gensler, Daniel, Müntze, Jonas, Ertl, Georg, Lorenz, Kristina, Frantz, Stefan, Weidemann, Frank, Nordbeck, Peter
Publicat a Cardiol Res Pract (2018)